September 27, 2017

Marathon Oil Corporation (NYSE:MRO) got OUTPERFORM rating from 6 analysts

Marathon Oil Corporation (NYSE:MRO)’s stock on Tuesday traded at beginning with a price of $13.09 and when day-trade ended the stock finally edged up 1.59% to reach at $13.40. Analyst’s mean target price for MRO is $15.84 while analysts mean recommendation is 2.40. Stock value has moved between $10.55 – 19.42 in last one year.

Stock has got OUTPERFORM rating from 6 analyst(s) whereas last month 6 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 6 analyst(s) given BUY rating to the stock. Company fiscal year is ending in December and analysts’ consensus recommendation is Outperform for MRO and estimated EPS for next quarter is $ -0.16 .

Marathon Oil Corporation (NYSE:MRO) yearly performance is -7.01%. Annual EPS Growth of past 5 years is -25.30%. The current share price indicates that stock is -30.50% away from its one year high and is moving 27.01% ahead of its 52-week low.

Roka Bioscience, Inc. (NASDAQ:ROKA)‘s stock on Tuesday traded at beginning with a price of $1.200 and when day-trade ended the stock finally plunged -23.99% to reach at $0.92. Analyst’s mean target price for ROKA is $10.00 while analysts mean recommendation is 2.00. Stock value has moved between $0.85 – 9.2 in last one year.

Roka Bioscience, Inc. (NASDAQ:ROKA) yearly performance is -86.55%. Annual EPS Growth of past 5 years is -7.90%. The current share price indicates that stock is -90.10% away from its one year high and is moving 8.35% ahead of its 52-week low.

On 26 September 2017, Air Industries Group (NYSE:AIRI) stock price started the day at $1.41 and moved between $1.38 – 1.50 to finally close at $1.46. AIRI’s distance from 20 day simple moving average is 3.14% and distance from 50-Day simple moving average is 4.91%. In last 4 months performance of AIRI was -20.65% while its price to sale ratio is 0.31 and price to book ratio is 0.46.

Analysts expect Air Industries Group (NYSE:AIRI) to report $ -0.14 EPS and has got OUTPERFORM rating from 1 of Thomson Reuters analysts and 0 analyst(s) given UNDERPERFORM rating. Analyst’s mean target price for AIRI is $3.88 while analysts mean recommendation is 2.00. Firm LT growth rate is estimated as 26.60 %.

Leave a Reply

Your email address will not be published. Required fields are marked *